Blog

Syed A. Ahmad: Our review on neoadjuvant and adjuvant therapy for resectable pancreas cancer

Photo taken from Syed A. Ahmad/X

May 20, 2024, 14:44

Syed A. Ahmad: Our review on neoadjuvant and adjuvant therapy for resectable pancreas cancer

Syed A. Ahmad, Director at University of Cincinnati Cancer Center & Chief of Surgical Oncology at University of Cincinnati, made the following post on X:

“Here is our review article on neoadjuvant and adjuvant therapy for resectable pancreas cancer.

Neoadjuvant and Adjuvant Therapy in Resectable Pancreatic Adenocarcinoma.”

Source: Syed A. Ahmad/X

Adjuvant Therapy cancer cancer treatment chemotherapy neoadjuvant therapy OncoDaily Oncology oncology research oncology review article pancreatic adenocarcinoma pancreatic cancer management radiation therapy resectable tumors surgical outcomes Syed A. Ahmad Treatment Strategies

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage